Optimi Health Income Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023
Revenue	0.23	0.43	0.39	0.18
Revenue Growth (YoY)	-53.24%	9.35%	115.28%	-
Cost of Revenue	0.34	0.41	0.24	0.15
Gross Profit	-0.2	0.02	0.15	0.03
Selling, General & Admin	4.32	3.78	5.05	4.28
Depreciation & Amortization Expenses	0.99	0.95	0.87	0.73
Research & Development	0.23	0.35	0.39	0.15
Other Operating Expenses	-	0.08	-0.12	0.01
Total Operating Expenses	5.54	5.16	6.19	5.17
Operating Income	-5.74	-5.14	-6.04	-5.14
Interest Income	0.01	0.01	0	0.14
Other Non-Operating Income (Expense)	0.51	1.42	-	-
Total Non-Operating Income (Expense)	0.53	1.43	0	0.14
Pretax Income	-5.22	-3.71	-6.04	-5.01
Net Income	-5.22	-3.71	-6.04	-5.01
Net Income to Common	-5.4	-3.71	-6.04	5.19
Shares Outstanding (Basic)	3	3	3	3
Shares Outstanding (Diluted)	3	3	3	3
Shares Change (YoY)	3.66%	7.20%	2.94%	-
EPS (Basic)	-1.69	-1.20	-2.10	-1.80
EPS (Diluted)	-1.69	-1.20	-2.10	-1.80
Free Cash Flow	-3.29	-2.72	-4.43	-4.41
Free Cash Flow Per Share	-1.02	-0.85	-1.49	-1.52
Gross Margin	-85.65%	3.66%	38.85%	17.76%
Operating Margin	-2477.14%	-1206.65%	-1548.94%	-2839.39%
Profit Margin	-2249.51%	-870.75%	-1548.25%	-2764.06%
FCF Margin	-1420.85%	-637.17%	-1137.38%	-2432.96%
EBITDA	-4.75	-4.19	-5.17	-4.41
EBITDA Margin	-2050.65%	-983.72%	-1326.30%	-2436.51%
EBIT	-5.74	-5.14	-6.04	-5.14
EBIT Margin	-2477.14%	-1206.65%	-1548.94%	-2839.39%